Resveratrol was reported to inhibit IL-1β-mediated apoptosis via regulation of caspase-3 activation and PARP cleavage, and reduce inflammatory signaling via inhibition of the degradation of IκBα in articular chondrocytes, suggesting that resveratrol might be a natural compound for treating osteoarthritis (129). This evidence concerns the gene IL1B and osteoarthritis.